Distribution Deals in Diagnostics 2016-2024


Distribution Deals in Diagnostics | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024

Publication date
March 2024
Number of pages
Product type
Research report
Available formats
PDF document
Report edition
4 - fully revised and updated

Distribution Deals in Diagnostics provides a detailed understanding and analysis of how and why companies enter distribution deals.

Fully revised and updated, the report provides details of distribution deals from 2016 to 2024.

The report provides access to distribution deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred – contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of distribution deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual distribution contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of distribution dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in distribution as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of distribution deals.

Chapter 4 provides a review of the leading distribution deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active distribution dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.  

The deal directory includes a comprehensive listing of all distribution deals announced since 2016. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in distribution dealmaking since 2016.

In conclusion, this report provides everything a prospective dealmaker needs to know about distribution alliances.


Key benefits

Distribution Deals in Diagnostics provides the reader with the following key benefits:

  • Understand deal trends since 2016
  • Browse distribution deals
  • Benchmark analysis – identify market value of transactions
  • Financials terms
  • Directory of deals by company A-Z, therapy focus and technology type
  • Leading deals by value
  • Most active dealmakers
  • Identify assets and deal terms for each transaction
  • Due diligence - assess suitability of your proposed deal terms for partner companies
  • Save hundreds of hours of research time


Report scope

Distribution Deals in Diagnostics is intended to provide the reader with an in-depth understanding of the distribution trends and structure of deals entered into by leading biopharma companies worldwide.

Distribution Deals in Diagnostics includes:

  • Trends in distribution dealmaking in the biopharma industry
  • Overview of distribution deal structure
  • Directory of distribution deal records covering diagnostics
  • The leading distribution deals by value
  • Most active distribution dealmakers
  • The leading distribution partnering resources


In Distribution Deals in diagnostics, the available deals are listed by:

  • Company A-Z
  • Headline value
  • Therapeutic area
  • Technology type


Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.

Distribution Deals in diagnostics provides comprehensive access to available records for distribution deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

  • What are the rights granted or optioned?
  • What rights are granted by the agreement?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are intellectual property rights handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Distribution Deals in Diagnostics provides the reader with the following key benefits:

  • Understand deal trends since 2016
  • Browse distribution deals
  • Benchmark analysis – identify market value of transactions
  • Financials terms
  • Directory of deals by company A-Z, therapy focus and technology type
  • Leading deals by value
  • Most active dealmakers
  • Identify assets and deal terms for each transaction
  • Due diligence - assess suitability of your proposed deal terms for partner companies
  • Save hundreds of hours of research time

Executive Summary


Chapter 1 – Introduction


Chapter 2 – Trends in distribution dealmaking

2.1. Introduction

2.2. Definition of distribution deal

2.3. Trends in distribution deals since 2016

2.3.1. Distribution dealmaking by year, 2016-2024

2.3.2. Distribution dealmaking by phase of development, 2016-2024

2.3.3. Distribution dealmaking by therapy area, 2016-2024

2.3.4. Distribution dealmaking by technology type, 2016-2024

2.3.5. Distribution dealmaking by most active company, 2016-2024

2.3.6  Attributes of pure distribution deals

2.3.7  Attributes of distribution in multi-component deals

2.4. Aligning partners to make the distribution agreement work


Chapter 3 – Overview of distribution deal structure

3.1. Introduction

3.2. Distribution agreement structure

3.3  Distribution rights part of a wider alliance agreement


Chapter 4 – Leading distribution deals

4.1. Introduction

4.2. Top distribution deals by value


Chapter 5 – Top 25 most active distribution dealmakers

5.1. Introduction

5.2. Top 25 most active distribution dealmakers


Chapter 6 – Distribution deals including contracts directory

6.1. Introduction

6.2. Distribution deals with contracts 2016 to 2024

Deal directory

Deal directory – distribution dealmaking by companies A-Z

Deal directory – distribution dealmaking by therapy area

Deal directory – distribution dealmaking by technology type


About Wildwood Ventures

Current Partnering

Current Agreements

Recent report titles from Current Partnering



Figure 1: Definition of distribution
Figure 2: Trends in distribution deal announcements, 2016 to 2024
Figure 3: Distribution deals signed at each phase of development, 2016 to 2024
Figure 4: Distribution deals by therapy area, 2016 to 2024
Figure 5: Distribution deals by technology type, 2016 to 2024
Figure 6: Top 25 most active distribution dealmakers, 2016 to 2024
Figure 7: Issues in implementing distribution agreements
Figure 8: Distribution agreements – what should a contract include?
Figure 9: Components of the distribution deal structure
Figure 10: Top distribution deals by value 2016 to 2024
Figure 11: Most active distribution dealmakers 2016 to 2024

Pricing options

  • $3,995: single-user (encrypted file - one user/device)
  • $5,995: multi-user (encrypted file - up to 5 users/devices)
  • $9,995: company (unencrypted file)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.


Our guarantee


Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.


Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)


Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.


Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by Evalon.


Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.


Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

1health.io, 2cureX, 3D BioMed, 4bases, 5-Diagnostics, 7D Surgical, 221b Foundation, Abacus Diagnostica, AB Analitica, Abbott Laboratories, Abbott Rapid Diagnostics, Abbvie, Abingdon Health, ABL Diagnostics, AB Scientific, Accelerate Diagnostics, Access BIO, AceCGT Life Science, ACIST Medical Systems, ACON Biotech, Acupath Laboratories, Acurable, AddLife, Adial Pharmaceuticals, Aditx Therapeutics, Admera Health, ADS, Advanced Accelerator Applications, Advanced Human Imaging, Advanced Medical German Company of Kuwait, Advanced Ultrasound Systems, Affinity Proteomics Uppsala, Africa Centres for Disease Control and Prevention, Africa Medical Supplies Platform, Africa Union, Agena Bioscience, Agendia, Agilent Technologies, Aidian, Aidoc, AI Metrics, Akers Biosciences, Ako Med, Akonni Biosystems, Alab, ALBOT Technologies, Alcanna, Alercell, Alfa Instruments, Al Farabi Medical Laboratories, Alfasigma, Algenex, AlgoMedica, Align Technology, ALK-Abello, Alliance Global FZ, Alltests Clinical Solutions, Alpha-Tec Systems, Alpha Imaging, Alveo Technologies, Al Zahrawi Medical Supplies, Ambu, A Menarini Diagnostics, American Medical Depot, Amoy Diagnostics, Anixa Biosciences, Annar Health Technologies, Anwa Medical, AnX Robotica, Aperiomics, Apollo Med Innovations, Applied BioCode, Aptitude Medical Systems, Arc Medical Design, Areum Bio, Aridea Solutions, Arima Genomics, AroCell, Arrow Diagnostics, Arteriomed, Ascensia Diabetes Care, Aspect Imaging, ASPiRA Labs, Astra Formedic, Atlas Genomics, Atomo Diagnostics, Atrys Health, AutoGenomics, Avacta, Avalon GloboCare, Avantis Medical Systems, Avellino Labs, Avricore Health, Avrobio, AXIM Biotechnologies, Axlab, Axon Diagnostics, Axon Lab, Axonlab, Aytu BioPharma, B.e. Imaging, Banner Health, Bardy Diagnostics, Bausch & Lomb, Baxter International, Bayer, Bayer Healthcare, BC Platforms, Beckman Coulter, Be Creative Lab, Becton Dickinson, Beijing Genomics Institute (BGI), Beijing Leadman Biochemistry, Beijing Podconley Pharmaceutical Technology and Development, BeMotion, Bertin Pharma, Bestbion, Better Living Now, BGI, BHR Pharma, Biim Ultrasound, Bill and Melinda Gates Foundation, Binx Health, Bio-Rad Laboratories, BioAsia, Biocartis, Biocept, BioCheck, Biodesix, BioDiscovery, BIOgenetiX, BioGX, Bioiatriki, BioIQ, Biokosmos, BioLab Sciences, Biolidics, Biolife Science, Biomedica Medizinprodukte, bioMerieux, Biomol International, Bioportugal Quimica Farmaceutica, Biostar, Biosynex, Biotecom, BioTecon Diagnostics, bioTRADING Benelux, Biotronik, Biovica, BL&H, BlackRidge Healthcare, Blue Cross Blue Shield Association, Blue Earth Diagnostics, BMV Medica, BND, Boditech Med, Boots UK, BostonGene, BPGbio, Bracco, Brain Scientific, BrainScope, Brik, Bucher Biotec, Buhlmann Laboratories, Burning Rock, Cambridge Bioscience, Cambridge Neurotech, Cancer Genetics, Canon, Canon Lifecare Solutions, Capitainer, Capital X-ray, CapsoVision, Capstone Health Alliance, Cardinal Health, Cardiologs, Care GB Plus, Carestream Health, Carolina Liquid Chemistries, CBD Vida, Cellex, Cell Microsystems, CellSafe, Celmatix, Celsee, Cencora, Centre for Probe Development and Commercialization, Cepheid, Cerca Biotech, Cerveau Technologies, Change Healthcare, Charles River Laboratories, Chembio Diagnostics, China Biotech Services, China Grand Pharma, China Grand Pharmaceutical, Chindex Medical Limited, ChromaCode, Chun Fo Pharmaceutical, Cipla, Circulogene, Citogen, Clarius Mobile Health, Clearbridge Biomedics, Cleveland Diagnostics, Clinton Health Access Initiative, CNC Biotech, Co-Defend, Co-Diagnostics, CoaChrom Diagnostica, Coala Life, Color Genomics, Conavi Medical, Concert Genetics, Concile, Contextual Genomics, Cooper Surgical, Core Diagnostics India, Cortechs.ai, CorTechs Labs, CorVascular, Cosmo Bio, Cosmo Pharmaceuticals, Cosmos Holdings, CQuentia, Cruinn Diagnostics, CS Medical, CStone Pharmaceuticals, Cureleads, CureMetrix, Curetis, Curium, Cyclotek, Cynvenio, Cypre, Dahui Biotech, Dante Genomics, Dante Labs, DarioHealth, DarwinHealth, DASA, Daxor, DCN Diagnostics, Decision Diagnostics, Device Technologies, Devyser Diagnostics, DexCom, DiaCarta, Diagen, Diagnostic Biochips, Diagnostic International Distribution, DiA Imaging Analysis, Diamedix, DIAN Diagnostics, Diesse Diagnostica Senese, Dilon Diagnostics, Disior, DKSH, DnaNudge, DNA Software, Dornier MedTech, Dr Ho Now Health Products, Dr Risch, Dynasty Castle Investments, DYNEX Technologies, E25Bio, Easton Pharmaceuticals, Echo Mind Ai, Eckert & Ziegler, Eczacıbasi-Monrol, EDX Medical, Eigen, EIKOS Care Medical, EKF Diagnostics, Eldan, Elesta, Eli Lilly, ELTA90 Group, EMC, eMed, EMM Life Science, Empire Genomics, Empowered Diagnostics, EndoChoice, EndoClot Plus, Endoluxe, Enlitic, Epic, Epredia, Epsilon, Essenlix, Euformatics, Eurobio, EuroClone, Euroimmun, European Health Centre Innovation, Evergreen Theragnostics, Everly Health, EverlyWell, Eversana, Everything Genetic, EvoEndo, Faes Farma, Fannin, Fibronostics, Fio, First Check Diagnostics, Fisher Healthcare, FJ Medical, FlexDex, Flirtey, Fluidigm, Fluxion Biosciences, Foundation Medicine, Fugene Genetics, Fujifilm, Fujirebio Diagnostics, Fukuda Denshi, Fulgent Genetics, G42 Healthcare, Galaxy Health Network, Gamidor Diagnostics, Gamma Medica, GC Lab Tech, Gedeon Richter, GE Healthcare, GEMCO Medical, Gemelli Biotech, Genecast, Geneoscopy, GenePeeks, GenePOC, GenesisCare, Genetic Analysis, Genetics Institute, Genetic Technologies, Genewell Biotechnology, GENinCode, GenomeDx, Genosity, Genotests, Genova Diagnostics, GenScript Biotech, Georges Francois Leclerc Center, Gibraltar Brothers and Associates, GIMDx, Ginkgo BioWorks, Global Dx, Global Good Fund, Global Medical Solutions, gMed Canada, Gnomegen, Goffin Molecular Technologies, Gold Standard Diagnostics, Gotect Diagnostic, Gradientech, Greater New York Hospital Association, Great Lakes Medical Laboratory, Green Cross Medical Science, Green Leaf Scientific, Group Vida, Grupo Ferrer, Grupo Terralpe, Guardant Health, Guerbet, Guided Therapeutics, Gyros Protein Technologies, Hainan Sinotau Pharmaceutical, HalioDx, Hardy Diagnostics, Harvard Bioscience, Healius, HealthCare Konnect, HealthLytix, HealthTab, HeartSciences, HekaBio, Helix2, HemaTone, Hemcheck, Hemex Health, Henry Schein, Hermes Medical Solutions, Herzog Surgical, HiloProbe, HistoSonics, Hitachi, Hitachi Medical Systems Europe, Holberg EEG, Horizon Discovery, Hospital Services, HTG Molecular Diagnostics, HuminTec, Hygea Precision Medicine, I-MED Pharma, Iberlab, Ibex Medical Analytics, iCAD, Idengene, IES Diagnostics, ILC Group, Illumigyn, Illumina, Imagia Canexia Health, ImaginAb, Imaging Biometrics, Imegen, Immuno Diagnostic, ImpediMed, IncellDx, Incepto Medical, Indigo Biosciences, Infinity BiologiX, InfoBionic, Inivata, Innosieve Diagnostics, Insighters Medical, Institut für Hämopathologie Hamburg, Instituto de Microecologia, Institut Pasteur, Integrity Applications, Inteleos, Intelerad Medical Systems, Interlab INTERAUTOMATIKA UAB, Interpace Diagnostics, Interscope, Intra Globus Biosystems, IntroMedic, IP Biotech, IPS Genomix, IQ-AI, IRE Elit, IsoPlexis, Istituto Diagnostico Varelli, Item, Ives EEG Solutions, Jana Care, JNC Medical, Juama, Jubilant Radiopharma, K-One MediTech, KA Imaging, Kantaro Biosciences, Karius, Katalyst Diagnostics, KDx Diagnostics, Kent Imaging, Kindstar Globalgene Technology, Konica Minolta, KUB Technologies, Kurabo, L1 Enterprises, L1 Systems, Lab21, LabForce, Laboratory Corporation of America, LabStyle Innovations, Lambell Ghana, Lantheus Holding, Launch Diagnostics, Leader Life Sciences, Leica Biosystems, Leica Microsystems, Leonie Hill Capital, Levi Biotech, Lexogen, LifeCell, LifeCodexx, LifeLabs Medical Laboratory Services, LifeScan, Lightsense Technology, Limaca Medical, Lobo Genetics, LOK, Lonza, Lucerna-Chem, Lucira Health, LumiraDx, Lumos Diagnostics, Lunaphore, Lunatus, Luscii, Lyric Health, Madison Core Laboratories, Magellan Health Services, Magentine, Mainz Biomed, Marubeni, Mast Group, Materia, Materialise, Matrix Medical Network, Maverick Health, Mayo Clinic BioPharma Diagnostics, McKesson, MDL Asia, MDNA Life Sciences, MDxHealth, MedAxiom, MedCom, Medexus Pharmaceuticals, Medical Imaging, Medical One, Medicinal Genomics, Medigus, Mediphos, MediReva, Medis, Medisur, Medline Industries, MedMira, Mednow, MedQuest, Medusa19, Medx, Menarini Silicon Biosystems, Merck KGaA, Meridian Health Services Network, Merit Medical Systems, Mesa Biotech, Mesa Laboratories, Metaoptima Technology, Methapharm, MGI Tech, Micro-Tech Endoscopy, Microbix Biosystems, MicroPort Sorin CRM (Shanghai), Microprofit Biotech, Milenia Labs, Miller Veterinary Supply East, MindChild Medical, Mindray Medical International, Minogue Medical, miR Scientific, MiRXES, Mitra Biotech, Mobidiag, Moldionics, Molecular Matrix, Molecular You, MolecuLight, MolGen, Mologic, Motic, MRIguidance, Multi G, Murdoch Childrens Research Institute, MyHealthChecked, MyLabBox, Myriad Genetics, Naka International, Nanjing Micro-Tech, Nano-X Imaging, Nanomix, Nanosonics, NanoSpot.ai, Nanowear, NantHealth, Natera, National Ultrasound, Natus Medical, Nautilus, Navidea Biopharmaceuticals, Navinci Diagnostics, Near Patient Diagnostics, NEC, Neogenomics, Neoteric Technology, Nephros, NeuMoDx Molecular, NeuroMetrix, NeuroOne, NeuSoft Medical Technologies, Newmars Group, NG Biotech, NGeneBio, Nima, Ninepoint Medical, NLC Pharma, Nonagen Bioscience, Nordic Medtech, Norgine, Norsk medisinsk syklotronsenter, Northern Diagnostics, NovaBay Pharmaceuticals, Novarad, Novarix, NovellusDx, Novigenix, Noviscend, Novo Integrated Sciences, Nucliber, NX Development, Nyxoah, Occum Health, Olympus, Omegen Molecular, Omnia, OncoLab Diagnostics, Oncotest, One Cell Diagnostics, One Lambda, OpGen, Opto-Systems, Optovue, OraSure Technologies, Orot+, Ortho-Clinical Diagnostics, Orthofix Medical, OSANG Healthcare, Otsuka America Pharmaceutical, Oxford Immunotec, Paige, Palex Medical, Paradigm, Paragon Genomics, Paralax Life Science Group, PathAI, Pathnova Laboratories, PathogenDx, Pathway Diagnostics, Patia, Pentapharm, Pentax, Peramare Pharmaceuticals, Peregrine Market Access, Peripal, PerkinElmer, Perry Baromedical, Personal Genome Diagnostics, Persown, PETNET Solutions, PharmaCare Management, PharmaLogic, Phi Life Sciences, Phosphorus Genomics, Photocure ASA, Pillar Biosciences, PixCell Medical, Planmed, Point of Care Diagnostics, Positive Bioscience, Positron, PreCheck, Precipio Diagnostics, Precision Diabetes, Precision Lens, PredictImmune, Predictive Health Diagnostics, Predictive Technology Group, Premas Life Sciences, Prenetics, Presagen, Previon, Prime Health Services, Primetech, Probo Medical, ProciseDx, Progentec Diagnostics, Pro Med Diagnostics, Promedica Bioelectronics, Proscia, Protean BioDiagnostics, ProtonDx, Qiagen, QuantumDx, Quaphaco, Quest Diagnostics, Quidel, Quironprevencion, R-Biopharm, Radiology Oncology Systems, RAM-Tech, RaySearch Laboratories, Reditus Laboratories, RegenLab, Relay Medical, Remote Medical International, RenalytixAI, ResearchDx, RevealDx, RevoluGen, Revvity, Richardson RFPD, Righton, Rijuven, Riken Genesis, Rite Aid, Roche, Roche Diagnostics, ROCOL, ROTOP Pharmaka, RSA Biomedical, Rubicon Genomics, Saladax Biomedical, Salignostics, Sansure Biotech, Sanvita, Sapphiros, SAS, Satio, Savonix, Saxonia Diagnostics, Sayre Therapeutics, Science for Life Laboratory, Sciex, Scintica Instrumentation, Scivita Medical Technology, Screenpoint Medical, Sectra, Seegene, Seibersdorf Laboratories, Sekisui Diagnostics, Self-screen, Sense Biodetection, Senseonics, Sera Prognostics, Serosep, Severn Safety Supply, Shanghai Fosun Long March Medical Science, Siemens Healthineers, Sirona Medical, SkylineDX, Smart Medical Systems, Smith & Nephew, SOLA Biosciences, Solaris, SomaLogic, Sonic Healthcare, Sonography Canada, SonoScape Medical, Sound Technologies, SouthGenetics, Speciality Diagnostix, Specialty Networks, Spectral Medical, Spectrum Medical, Spectrum Solutions, SpeeDx, SpePharm, SPI Medical, Spirosure, SRL, Stago, Stone Diagnostics, Stratech Scientific, Stratis Medical, Streck Laboratories, Subtle Medical, Sugentech, Svar Life Science, Swixx Biopharma, SyntheticMR, Sysmex, Sysmex America, Sysmex Inostics, T2 Biosystems, Tabula Rasa HealthCare, Tecan, Technopath Clinical Diagnostics, TECOmedical, Teleflex, Telix Pharmaceuticals, Teneovita Medical, TeraRecon, Terason, TestDNA, Theradiag, Theragnostics, Theranostica, Therma Bright, Thermo Fisher Scientific, Thomas Scientific, Todos Medical, Tosoh, Touchstone Medical Imaging, Tri-anim Health Services, Triage Technologies, Triolab, Trivector Biomed, Truepill, TTG Imaging Solutions, Tucker Medical, Turner Imaging Systems, Ubiquitome, Ulrich Medical Concepts, Una Health, Unilabs, University College London, University of California, University of Helsinki, University of Zurich, UPPI, UroGPO, US Oncology, US Radiology Specialists, UVision360, Vatech, Vault Health, Vector Pharma FZCO, Vector Remote Care, Vela Diagnostics, Velsera, Veracyte, Verax Biomedical, Versea Ophthalmics, Victorian Clinical Genetics Services, Vida Diagnostics, ViewRay, Vigilant Biosciences, VIPUN Medical, Virax Biolabs Group, Virocule, Visby Medical, Visiopharm, Vitro, Vivera Pharmaceuticals, VolitionRX, Volpara Solutions, Vyaire Medical, WaveForm Technologies, Webb Diagnostic Technologies, Wellgistics, Werfen Group, Wiik Pharma, Windsor Pharmaceuticals, Wision AI, Wren Laboratories, Wuxi Apptec Laboratory Services, XboXLab, Xiamen Encheng Group, Xiel, XPhyto Therapeutics, YourRad, Zecotek Photonics, Zef Scientific, Ziehm Imaging, Zimmer Biomet, Zionexa, Zomedica

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.

We found other products you might like!